GH Research (GHRS)
GH Research Statistics
Share Statistics
GH Research has 52.03M shares outstanding. The number of shares has increased by 0% in one year.
| Shares Outstanding | 52.03M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 30.44M |
| Failed to Deliver (FTD) Shares | 3.54K |
| FTD / Avg. Volume | 4.77% |
Short Selling Information
The latest short interest is 1.91M, so 3.67% of the outstanding shares have been sold short.
| Short Interest | 1.91M |
| Short % of Shares Out | 3.67% |
| Short % of Float | 6.27% |
| Short Ratio (days to cover) | 30.57 |
Valuation Ratios
The PE ratio is -8.48 and the forward PE ratio is -7.96.
| PE Ratio | -8.48 |
| Forward PE | -7.96 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 1.38 |
| P/FCF Ratio | -9.02 |
| PEG Ratio | n/a |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for GH Research.
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 24.49, with a Debt / Equity ratio of 0.
| Current Ratio | 24.49 |
| Quick Ratio | 24.49 |
| Debt / Equity | 0 |
| Total Debt / Capitalization | 0.44 |
| Cash Flow / Debt | -34.23 |
| Interest Coverage | -57.02 |
Financial Efficiency
Return on equity (ROE) is -0.16% and return on capital (ROIC) is -18.74%.
| Return on Equity (ROE) | -0.16% |
| Return on Assets (ROA) | -0.16% |
| Return on Capital (ROIC) | -18.74% |
| Revenue Per Employee | 0 |
| Profits Per Employee | -726.27K |
| Employee Count | 49 |
| Asset Turnover | 0 |
| Inventory Turnover | 0 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by 21.46% in the last 52 weeks. The beta is 0.74, so GH Research's price volatility has been higher than the market average.
| Beta | 0.74 |
| 52-Week Price Change | 21.46% |
| 50-Day Moving Average | 8.5 |
| 200-Day Moving Average | 9.94 |
| Relative Strength Index (RSI) | 55.51 |
| Average Volume (20 Days) | 74.05K |
Income Statement
| Revenue | n/a |
| Gross Profit | -315.00K |
| Operating Income | -41.22M |
| Net Income | -35.59M |
| EBITDA | -41.15M |
| EBIT | n/a |
| Earnings Per Share (EPS) | -0.68 |
Balance Sheet
The company has 78.42M in cash and 974.00K in debt, giving a net cash position of 77.45M.
| Cash & Cash Equivalents | 78.42M |
| Total Debt | 974.00K |
| Net Cash | 77.45M |
| Retained Earnings | -67.94M |
| Total Assets | 199.61M |
| Working Capital | 145.16M |
Cash Flow
In the last 12 months, operating cash flow was -33.34M and capital expenditures -100.00K, giving a free cash flow of -33.44M.
| Operating Cash Flow | -33.34M |
| Capital Expenditures | -100.00K |
| Free Cash Flow | -33.44M |
| FCF Per Share | -0.64 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
GHRS does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -7.56% |
| FCF Yield | -7.14% |
Analyst Forecast
The average price target for GHRS is $39, which is 333.3% higher than the current price. The consensus rating is "Buy".
| Price Target | $39 |
| Price Target Difference | 333.3% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Scores
| Altman Z-Score | 26.42 |
| Piotroski F-Score | 2 |